Savara Pharmaceuticals
SVRA
#6616
Rank
ยฃ0.43 B
Marketcap
ยฃ2.53
Share price
-1.23%
Change (1 day)
-30.25%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -ยฃ64.45 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ43.01 Million a decrease over its 2022 earnings that were of -ยฃ30 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ64.45 Million49.85%
2023 -ยฃ43.01 Million43.38%
2022 -ยฃ30 Million-11.31%
2021 -ยฃ33.83 Million-13.3%
2020 -ยฃ39.02 Million-36.53%
2019 -ยฃ61.47 Million13.76%
2018 -ยฃ54.04 Million105.54%
2017 -ยฃ26.29 Million34.11%
2016 -ยฃ19.61 Million-37.43%
2015 -ยฃ31.33 Million38.81%
2014 -ยฃ22.57 Million33.62%
2013 -ยฃ16.9 Million38.49%
2012 -ยฃ12.2 Million24.59%
2011 -ยฃ9.79 Million-36.5%
2010 -ยฃ15.42 Million-3.14%
2009 -ยฃ15.92 Million-23.28%
2008 -ยฃ20.75 Million8.52%
2007 -ยฃ19.12 Million-34.14%
2006 -ยฃ29.03 Million184.43%
2005 -ยฃ10.21 Million90.75%
2004 -ยฃ5.36 Million190.35%
2003 -ยฃ1.85 Million11.64%
2002 -ยฃ1.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ14.28 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ92.66 Million 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA